Dr. med. Wolfgang Rohrer, Klosters, Switzerland
Treating rheumatic disorders with the chemotherapeutic agents known to conventional medicine (methotrexate, leflunomide, etc.) frequently presents difficult problems for the patient as well as the physician. The potential side effects of these drugs, in particular, can be extremely unpleasant for the patient and create real problems for the physician.
One possible approach using BICOM® bioresonance therapy is demonstrated through two case histories (44 year old male, 64 year old female) with seropositive rheumatoid arthritis. The diagnosis and continuing treatment of both cases over a 21/2 year period is well documented both clinically and through laboratory tests.
Typical chemotherapeutic agents were not used on the male patient while they had to be discontinued on the female patient due to serious side effects.
The younger patient experienced complete remission using BICOM® bioresonance therapy while a marked improvement ...